Cosette Pharmaceuticals

Stamp with blue ink that says FDA Approved
Pharma

Cosette lands FDA approval for Evoxac liquid in Sjögren’s

Evoxac was part of a multi-product transaction Cosette penned with Daiichi back in 2022, as the Japanese pharma shifted its focus to oncology.
Angus Liu Oct 20, 2026 11:22am
Withdraw cancel rip up application

Australian government blocks Cosette's Mayne Pharma buy

Nov 21, 2025 11:36am
illustration of two people putting puzzle pieces together merger and acquisition concept

Cosette snaps up Mayne Pharma for $430M

Feb 21, 2025 11:20am
Vyleesi

Cosette buys female libido drug Vyleesi from Palatin

Dec 20, 2023 11:53am
Office building showing Daiichi Sankyo logo

Daiichi Sankyo relinquishes rights to 8 cardio drugs to Cosette

Jan 18, 2022 7:35am
arms and fists

Cosette to add liquids to its mix with deal for 2nd plant

Nov 7, 2019 9:48am